Y. Shatokhin

Some characteristics of patients with myelodysplastic syndrome

P. Lipilkin, Y. Shatokhin, A. A. Matsuga, 2020, Medical Herald of the South of Russia.

Myelodysplastic syndrome: epidemiology, diagnostics and epigenetic disorders

P. Lipilkin, Y. Shatokhin, E. D. Kulaeva, 2022, Medical Herald of the South of Russia.

KIDNEY INJURY IN CANCER THERAPY

Y. Shatokhin, A. A. Matsuga, E. Burnasheva, 2018, Nephrology (Saint-Petersburg).

[The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial].

V. Mazurov, T. Konstantinova, M. Morozova, 2021, Terapevticheskii arkhiv.

National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)

B. Afanasyev, A. Sudarikov, A. Kovrigina, 2021 .

Contribution of social and demographic parameters to the long-term survival prognosis of chronic myeloid leukemia patients

T. Konstantinova, E. Parovichnikova, V. Savchenko, 2021, Russian journal of hematology and transfusiology.

Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia

A. Lavrov, S. Kutsev, A. Turkina, 2017, PloS one.

Clinical observation of Erdheim–Chester disease: diagnostic difficulties, treatment options

Y. Shatokhin, A. A. Matsuga, A. Zeltser, 2024, South Russian Journal of Therapeutic Practice.